Leading Imaging CRO Opens New Operations Facility in Basel
Boston, MA, November 6, 2015 – WorldCare Clinical (WCC), a leading provider of imaging services for clinical trials, today announced that it has expanded its European operations to include an office in Basel, Switzerland. The office adds to WorldCare Clinical’s scientific and operational reach in support of clinical trials and sites throughout Europe. Scientific, project management and imaging operations staff are based in the new office, providing on-the-ground access to expertise for WorldCare Clinical customers.
"For more than 20 years, WorldCare Clinical has supported our customers with imaging services on hundreds of clinical trials across thousands sites in Europe for both global and region-specific trials,” stated Aaron Timm, CEO of WorldCare Clinical. “Adding an office in a global hub of the pharmaceutical industry supports our mission of providing the industry’s highest quality of scientific and operational support for our customers."
WCC works globally with an extensive network of board-certified, sub-specialty trained radiologists, as well as key opinion leaders and imaging specialists based in Europe.
About WorldCare Clinical
WorldCare Clinical is a global imaging CRO that employs scientific expertise, innovative technology, and operational excellence to maximize the precision and accuracy of a blinded independent central review of Phase I – IV clinical trial data. The company has worked with thousands of sites in more than 60 countries. WCC’s robust technology platform processes over 250 million images annually (CT, MRI, X-Ray, Echo, US, PET). Originally founded in 1992 by the Massachusetts General Hospital (MGH) Department of Radiology, WorldCare continues to maintain a strategic relationship with the Harvard Hospital System as well as other leading academic institutions.